Literature DB >> 17332762

Causes of blind certifications in England and Wales: April 1999-March 2000.

C Bunce1, R Wormald.   

Abstract

AIM: The last complete report on causes of blindness in England and Wales was for data collected during April 1990 to March 1991. This current study sought to update these figures, with data collected during April 1999 to March 2000, and examine variation in cause by age group.
METHODS: In England and Wales, registration for blindness is voluntary and is initiated by certification by a consultant ophthalmologist. The main cause of blindness was ascertained where possible for all certificates completed during April 1999 to March 2000 and tabulated by age group.
RESULTS: A total of 34 410 BD8 certificates were received, of which 13 788 (40%) were for people certified as blind. Different causes predominated within different age groups. Age related macular degeneration (AMD) was the lead cause in those aged 65 years and above, diabetic retinopathy was the lead cause in people of working ages (16-64 years), whereas cerebral visual impairment and disorders of the optic nerve accounted for over 40% of blind certificates completed for children.
CONCLUSION: Estimates of vision impairment based on certifications for blindness in England and Wales are likely to be imprecise. They do, however, give some measure of the burden at hospital level of sight impairing eye conditions. If factors determining the imprecision remain constant, temporal monitoring of causes may enable changes and development of new conditions leading to vision impairment to be detected.

Entities:  

Mesh:

Year:  2007        PMID: 17332762     DOI: 10.1038/sj.eye.6702767

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  40 in total

1.  Diabetic retinopathy equity profile in a multi-ethnic, deprived population in Northern England.

Authors:  M Kliner; G Fell; C Gibbons; M Dhothar; M Mookhtiar; A Cassels-Brown
Journal:  Eye (Lond)       Date:  2012-02-03       Impact factor: 3.775

2.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

3.  Trends in serious ocular trauma in Scotland.

Authors:  P Desai; D S Morris; D C Minassian; C J MacEwen
Journal:  Eye (Lond)       Date:  2015-02-13       Impact factor: 3.775

4.  Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice.

Authors:  B Gupta; R Wong; S Sivaprasad; T H Williamson
Journal:  Eye (Lond)       Date:  2012-01-13       Impact factor: 3.775

5.  United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services.

Authors:  T D L Keenan; R L Johnston; P H J Donachie; J M Sparrow; I M Stratton; P Scanlon
Journal:  Eye (Lond)       Date:  2013-09-20       Impact factor: 3.775

6.  Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study.

Authors:  C Wilde; A Poostchi; R L Mehta; H K MacNab; J G Hillman; S A Vernon; W M Amoaku
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

7.  Mechanisms compensating for visual field restriction in adolescents with damage to the retro-geniculate visual system.

Authors:  L Jacobson; F Lennartsson; T Pansell; G Oqvist Seimyr; L Martin
Journal:  Eye (Lond)       Date:  2012-09-21       Impact factor: 3.775

8.  Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.

Authors:  Jeannette J Yu; Elvira Agrón; Traci E Clemons; Amitha Domalpally; Freekje van Asten; Tiarnan D Keenan; Catherine Cukras; Emily Y Chew
Journal:  Ophthalmology       Date:  2018-08-22       Impact factor: 12.079

Review 9.  Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema.

Authors:  Hemal Mehta; Mark Gillies; Samantha Fraser-Bell
Journal:  Ther Adv Chronic Dis       Date:  2015-09       Impact factor: 5.091

10.  [Blindness in Germany: dimensions and perspectives].

Authors:  R P Finger
Journal:  Ophthalmologe       Date:  2007-10       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.